Pfizer

NEWS DESK

Pfizer Appoints Elif Aral as Regional President for the Middle East, Russia & Africa

News Desk 1 05/09/2024

Pfizer announces the appointment of Elif Aral as Regional President for Middle East, Russia, and Africa (MERA) effective September 2024 to spearhead operations in the region and bring scientific breakthroughs in vaccines, oncology, rare diseases, internal medicine, hospitals, and inflammation

Business

Pfizer Celebrates 175 Years Of Healthcare Innovation

Arnold Pinto 15/06/2024 0

With Focus On Legacy And Future Breakthroughs Pfizer is committed to driving healthcare innovation, improving healthcare access, and continuing its legacy of transformative medical breakthroughs for years to come. This is the key messaging delivered by Patrick van der Loo, Regional President for the Middle East, Russia, and Africa (MERA) region, as the New

NEWS DESK

Five Year Follow-Up Data of Pfizer’s CROWN Trial Shows Prolonged Progression-Free Survival in ALK-Positive Advanced Lung Cancer

News Desk 2 03/06/2024

Pfizer has announced longer-term follow-up results from the Phase 3 CROWN trial, evaluating Lorlatinib, a lung cancer treatment in people with previously untreated, anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC). After five years of median follow-up, median progression-free survival (PFS) based on investigator assessment showed an 81

NEWS DESK

Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS

News Desk 2 03/06/2024

Takeda (TSE:4502/NYSE:TAK) and Pfizer (NYSE: PFE) today announced that the German Hodgkin Study Group (GHSG) will present positive results from the Phase 3 HD21 trial evaluating ADCETRIS® (brentuximab vedotin) in combination with chemotherapy as a late-breaking oral presentation at the 60th American Society of Clinical Oncology (ASCO) Annual Meeting

NEWS DESK

New Dawn for Severe Alopecia Areata Patients in UAE: Pfizer’s New Breakthrough Unveiled

News Desk 2 21/05/2024

Alopecia areata, an autoimmune disease characterized by patchy or complete hair loss on the scalp, face or body, has long been a challenge for individuals worldwide[1],[2]. Today, Pfizer announces a groundbreaking advancement in the treatment of severe alopecia areata in the UAE for patients as young as 12 years old. This new once-daily oral capsule […]

NEWS DESK

New hope for a once neglected disease

News Desk 2 13/05/2024

To further highlight its commitment on improving patient outcomes in the Gulf, Pfizer hosted a media roundtable to raise awareness on Sickle Cell Disease (SCD) and revealed key findings from Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) Survey conducted in several countries including GCC. Attended by leading healthcare professionals, the roundtable

NEWS DESK

Pfizer launches RSV awareness campaign in UAE to help safeguard your health

News Desk 2 30/04/2024

Pfizer launched a comprehensive awareness campaign in UAE to raise awareness on Respiratory Syncytial Virus (RSV) and the proactive measures that can be taken to help prevent this disease and keep your loved ones healthy and happy. Through collaborative efforts with Healthcare Professionals, Pfizer hosted an informative media roundtable aimed to highlight the importance of

NEWS DESK

Pfizer Launches ‘Know. Plan. Go.’ Campaign

News Desk 2 14/06/2023

Dubai, United Arab Emirates – 14 June 2023 – Pfizer rolls out ‘Know. Plan. Go.’ campaign in countries across the Gulf region to raise awareness on viral respiratory diseases and the steps people can take to help prevent severe illness. Viral respiratory infections often peak over winter, but some can circulate year-round1. It is crucial […]